Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Ziad Bakouny, MD, Dana-Farber Cancer Institute, Boston, MA, discusses his analysis of cytoreductive nephrectomy for metastatic renal cell carcinoma (RCC) treated with immune checkpoint inhibitors or targeted therapy. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.